Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Scientist

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Feb 28, 2021

View more

Discipline
Science/R&D, Biotechnology
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Genetown

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We want all of our people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just treat people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

SUMMARY:

Intellia Therapeutics is seeking an experienced Senior Scientist to join the RNA Chemistry Team, which is responsible for the production of synthetic oligonucleotides. This individual will be involved in a complete production process for the identification, implementation & fulfillment of synthesis, purification and reaction scheme analytical characterization and method development of oligonucleotides.

RESPONSIBILITIES:
  • Be the key go-to person with strong hands-on experience and detailed knowledge of oligonucleotides.
  • Execute synthesis, deprotection, purification, & downstream processing of oligonucleotides.
  • Operate, maintain & calibrate synthesis platforms and other scientific equipment.
  • Design & implement semi-preparative, analytical HPLC and LC-MS quality control processes.
  • Continuous synthetic oligonucleotide method and process development.
  • Solid decision-making on product path with the ability to work independently and collaboratively while problem-solving.
  • Demonstrate lab competency in preparing reagents and buffers & handling chemicals.
  • Write and follow standard operating procedures and process improvement documents.
  • Documentation of results and data analysis.
  • Ensure safety and product quality are paramount throughout the laboratory environment.


QUALIFICATIONS:
  • Ph.D. in Chemistry, Biochemistry, Biochemical or Chemical engineering or related discipline with at least 2 years experience, preferably in an industrial drug discovery setting.
  • MS with 8 years and BS with 10 years of experience will also be considered.
  • Basic computer skills including MS Office Suite.
  • Attention to detail
  • Exceptional time management
  • Effective communicator
  • Capable of repetitive tasks and performing other duties as assigned


#LI-DG1

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert